Specific immunotherapy in the complex treatment of ovarian cancer

O. V. Makarov; Макаров О. В.; A. A. Krotenko; Кротенко А. А.; V. N. Kosetsky; Косецкий В. Н.; I. G. Sidorovich; Сидорович И. Г.; V. I. Novikov; Новиков В. И.; A. A. Vlasov; Власов А. А.

doi:10.17816/JOWD89248

Specific immunotherapy in the complex treatment of ovarian cancer

Authors: Makarov O.V.¹, Krotenko A.A.², Kosetsky V.N.¹, Sidorovich I.G.¹, Novikov V.I.¹, Vlasov A.A.¹
Affiliations:
1. Russian State Medical University
2. Russian State Medical UniversityА.А. Кротенко
Issue: Vol 50, No 1 (2001)
Pages: 43-46
Section: Scientific activity
URL: https://journals.rcsi.science/jowd/article/view/89248
DOI: https://doi.org/10.17816/JOWD89248
ID: 89248

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The article is devoted to the search for new solutions in the field of treatment of malignant ovarian tumors and, in particular, new approaches for overcoming immune resistance in a complex method of therapy. The experience of treating this pathology with an original method of postoperative immunotherapy using autologous immunomodulators, which, due to its simplicity and relatively low cost, should be widely used in gynecological oncology, is considered.